David Windley
Stock Analyst at Jefferies
(4.49)
# 793
Out of 5,182 analysts
209
Total ratings
66.39%
Success rate
13.9%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $340 → $373 | $354.69 | +5.16% | 29 | Apr 20, 2026 | |
| ELV Elevance Health | Maintains: Buy | $395 → $391 | $356.13 | +9.79% | 2 | Apr 20, 2026 | |
| CI The Cigna Group | Maintains: Buy | $333 → $330 | $282.58 | +16.78% | 18 | Apr 20, 2026 | |
| CNC Centene | Maintains: Hold | $37 → $39 | $43.50 | -10.34% | 29 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgrades: Hold | $10 → $16 | $17.18 | -6.87% | 2 | Apr 20, 2026 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $175 → $135 | $103.21 | +30.80% | 16 | Feb 23, 2026 | |
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $421.37 | +32.90% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $223.62 | +5.09% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $163.84 | +55.64% | 6 | Feb 6, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $79.00 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $9.5 | $10.60 | -10.38% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $142 → $195 | $171.23 | +13.88% | 20 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $263 | $222.19 | +18.37% | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2.75 | $0.92 | +199.60% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $179.22 | +65.72% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.29 | +1,186.89% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $470.99 | -20.38% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.81 | -1.96% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $160.45 | +68.28% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $6.24 | +148.40% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $302.20 | +77.37% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $16.18 | +79.23% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $5.85 | +4,139.32% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.90 | - | 5 | Oct 9, 2017 |
UnitedHealth Group
Apr 20, 2026
Maintains: Buy
Price Target: $340 → $373
Current: $354.69
Upside: +5.16%
Elevance Health
Apr 20, 2026
Maintains: Buy
Price Target: $395 → $391
Current: $356.13
Upside: +9.79%
The Cigna Group
Apr 20, 2026
Maintains: Buy
Price Target: $333 → $330
Current: $282.58
Upside: +16.78%
Centene
Apr 20, 2026
Maintains: Hold
Price Target: $37 → $39
Current: $43.50
Upside: -10.34%
Oscar Health
Apr 20, 2026
Upgrades: Hold
Price Target: $10 → $16
Current: $17.18
Upside: -6.87%
ICON Public Limited Company
Feb 23, 2026
Upgrades: Buy
Price Target: $175 → $135
Current: $103.21
Upside: +30.80%
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $421.37
Upside: +32.90%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $223.62
Upside: +5.09%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $163.84
Upside: +55.64%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $79.00
Upside: -
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $10.60
Upside: -10.38%
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $171.23
Upside: +13.88%
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $222.19
Upside: +18.37%
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $0.92
Upside: +199.60%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $179.22
Upside: +65.72%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.29
Upside: +1,186.89%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $470.99
Upside: -20.38%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.81
Upside: -1.96%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $160.45
Upside: +68.28%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $6.24
Upside: +148.40%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $302.20
Upside: +77.37%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $16.18
Upside: +79.23%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $5.85
Upside: +4,139.32%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.90
Upside: -